Abstract
In recent years a number of countries have extended prescribing rights to pharmacists in a variety of formats. The latter includes independent prescribing, which is a developing area of practice for pharmacists in secondary care. Potential opportunities presented by wide scale implementation of pharmacist prescribing in secondary care include improved prescribing safety, more efficient pharmacist medication reviews, increased scope of practice with greater pharmacist integration into acute patient care pathways and enhanced professional or job satisfaction. However, notable challenges remain and these need to be acknowledged and addressed if a pharmacist prescribing is to develop sufficiently within developing healthcare systems. These barriers can be broadly categorised as lack of support (financial and time resources), medical staff acceptance and the pharmacy profession itself (adoption, implementation strategy, research resources, second pharmacist clinical check). Larger multicentre studies that investigate the contribution of hospital-based pharmacist prescribers to medicines optimisation and patient-related outcomes are still needed. Furthermore, a strategic approach from the pharmacy profession and leadership is required to ensure that pharmacist prescribers are fully integrated into future healthcare service and workforce strategies.
References
Emmerton L, Marriott J, Bessell T, Nissen L, Dean L. Pharmacists and prescribing rights: review of international developments. J Pharm Pharm Sci. 2005;8:217–25.
Baqir W, Miller D, Richardson G. A brief history of pharmacist prescribing in the UK. Eur J Hosp Pharm Sci Pract. 2012;19:487–8.
Yuksel N, Eberhart G, Bungard TJ. Prescribing by pharmacists in Alberta. Am J Health Syst Pharm. 2008;65:2126–32.
Phelps A, Agur M, Nass L, Blake M. GPhC Registrant Survey 2013. General Pharmaceutical Council 2014. http://www.pharmacyregulation.org/sites/default/files/gphc_registrant_survey_2013_main_report_by_natcen.pdf. Accessed 10 Nov 2015.
Hinchliffe A. Pharmacist independent prescribing-a review of the evidence. NHS Wales 2015. https://www2.nphs.wales.nhs.uk/PharmaceuticalPHTDocs.nsf/($All)/45E9469550B09BB280257DF6004058CE/$File/Pharmacist%20independent%20prescribingv1.1.pdf?OpenElement. Accessed 27 Aug 2015.
Al Hamarneh YN, Charrois T, Lewanczuk R, Tsuyuki RT. Pharmacist intervention for glycaemic control in the community (the RxING study). BMJ Open. 2013;3:e003154.
Houle SK, Chuck AW, McAlister FA, Tsuyuki RT. Effect of a pharmacist managed hypertension program on health system costs: an Evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN). Pharmacotherapy. 2012;32:527–37.
McAlister FA, Majumdar SR, Padwal RS, Fradette M, Thompson A, Buck B, et al. Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial. CMAJ. 2014;186:577–84.
Tsuyuki R, Houle S, Charrois T, Kolber M, Rosenthal M, Lewanczuk R, et al. A randomized trial of the effect of pharmacist prescribing on improving blood pressure in the community: the Alberta clinical trial in optimizing hypertension (RxACTION). Circulation. 2015;132:93–100.
Health Education England. Investing in people for health and healthcare. Workforce plan for England. Proposed education and training commisions for 2014–15. 2014. http://hee.nhs.uk/wp-content/uploads/sites/321/2013/12/Workforce-plan-investing-in-people.pdf. Accessed 27 Aug 2015.
Scottish Government Department of Health and Wellbeing. Prescription for excellence: a vision and action plan for the right pharmaceutical care through integrated partnerships and innovation. 2013. http://www.gov.scot/resource/0043/00434053.pdf. Accessed 27 Aug 2015.
Tonna AP, Stewart DC, West B, McCaig DJ. Exploring pharmacists’ perceptions of the feasibility and value of pharmacist prescribing of antimicrobials in secondary care in Scotland. Int J Pharm Pract. 2010;18:312–9.
National Institute for Health and Care Excellence. Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes. 2015. https://www.nice.org.uk/guidance/ng5. Accessed 27 Aug 2015.
Dornan T, Ashcroft D, Heathfield H, Lewis P, Miles J, Taylor D, et al. An in depth investigation into causes of prescribing errors by foundation trainees in relation to their medical education. EQUIP study. General Medical Council, 2009. http://www.gmc-uk.org/FINAL_Report_prevalence_and_causes_of_prescribing_errors.pdf_28935150.pdf. Accessed 27 Aug 2015.
Ryan C, Ross S, Davey P, Duncan EM, Francis JJ, Fielding S, et al. Prevalence and causes of prescribing errors: the PRescribing Outcomes for Trainee doctors Engaged in Clinical Training (PROTECT) study. PLoS One. 2014;9:e79802.
Dean B, Schachter M, Vincent C, Barber N. Causes of prescribing errors in hospital inpatients: a prospective study. Lancet. 2002;359:1373–8.
Ross S, Ryan C, Duncan EM, Francis JJ, Johnston M, Ker JS, et al. Perceived causes of prescribing errors by junior doctors in hospital inpatients: a study from the PROTECT programme. BMJ Qual Saf. 2013;22:97–102.
Tully MP. Prescribing errors in hospital practice. Br J Clin Pharmacol. 2012;74:668–75.
Baqir W, Crehan O, Murray R, Campbell D, Copeland R. Pharmacist prescribing within a UK NHS hospital trust: nature and extent of prescribing, and prevalence of errors. Eur J Hosp Pharm Sci Pract. 2014;22:79–82.
Onatade R, Al-Azeib S, Gore S. Description and evaluation of the quality of pharmacist-written discharge medication. Int J Pharm Pract. 2014;22(S2):82–83.
Seden K, Kirkham JJ, Kennedy T, Lloyd M, James S, Mcmanus A, et al. Cross-sectional study of prescribing errors in patients admitted to nine hospitals across North West England. BMJ Open. 2013;3:e002036.
Graabæk T, Kjeldsen LJ. Medication reviews by clinical pharmacists at hospitals lead to improved patient outcomes: a systematic review. Basic Clin Pharmacol Toxicol. 2013;112:359–73.
Marotti SB, Kerridge RK, Grimer MD. A randomised controlled trial of pharmacist medication histories and supplementary prescribing on medication errors in postoperative medications. Anaesth Intensive Care. 2011;39:1064–70.
Mergenhagen KA, Blum SS, Kugler A, Livote EE, Nebeker JR, Ott MC, et al. Pharmacist- versus physician-initiated admission medication reconciliation: impact on adverse drug events. Am J Geriatr Pharmacother. 2012;10:242–50.
Tonna A, Stewart D, West B, McCaig D. Pharmacist prescribing in the UK—a literature review of current practice and research. J Clin Pharm Ther. 2007;32:545–56.
Latter S, Blenkinsopp A. Non-medical prescribing: current and future contribution of pharmacists and nurses. Int J Pharm Pract. 2011;19:381–2.
Royal Pharmaceutical Society. Improving Urgent and Emergency Care through better use of pharmacists. 2014. http://www.rpharms.com/policy-pdfs/urgent-and-emergency-care.pdf. Accessed 27 Aug 2015.
Weeks GR, Ciabotti L, Gorman E, Abbott L, Marriott JL, George J. Can a redesign of emergency pharmacist roles improve medication management? A prospective study in three Australian hospitals. Res Social Adm Pharm. 2014;10:679–92.
Rosenthal MM, Houle SK, Eberhart G, Tsuyuki RT. Prescribing by pharmacists in Alberta and its relation to culture and personality traits. Res Social Adm Pharm. 2015;11:401–11.
Hassell K. GPhC Register Analysis 2011. Centre for Pharmacy Workforce Studies 2012. http://www.pharmacyregulation.org/sites/default/files/Analysis%20of%20GPhC%20Pharmacist%20Register%202011.pdf. Accessed 10 Nov 2015.
Buckley P, Grime J, Blenkinsopp A. Inter-and intra-professional perspectives on non-medical prescribing in an NHS trust. Pharm J. 2006;277:394–8.
Royal Pharmaceutical Society. Medicines Optimisation: Helping patients to make the most of medicines. 2013. https://www.rpharms.com/promoting-pharmacy-pdfs/helping-patients-make-the-most-of-their-medicines.pdf. Accessed 27 Aug 2015.
Rosenthal M, Austin Z, Tsuyuki RT. Are pharmacists the ultimate barrier to pharmacy practice change? Can Pharm J. 2010;143:37–42.
Bourne RS, Whiting P, Brown LS, Borthwick M. Pharmacist independent prescribing in critical care: results of a national questionnaire to establish the 2014 UK position. Int J Pharm Pract. 2015;. doi:10.1111/ijpp.12219.
Medical Education England. Modernising Pharmacy Careers programme. Pharmacist Prescriber Training Working Group Report. 2010. http://hee.nhs.uk/healtheducationengland/files/2012/10/Pharmacist-Prescriber-Training-Report-for-MPC.pdf. Accessed 27 Aug 2015.
Tonna A, McCaig D, Diack L, West B, Stewart D. Development of consensus guidance to facilitate service redesign around pharmacist prescribing in UK hospital practice. Int J Clin Pharm. 2014;36:1069–76.
Royal Pharmaceutical Society. Professional Standards for Hospital Pharmacy Services. Optimising Patient Outcomes from Medicines. 2014. http://www.rpharms.com/support-pdfs/rps—professional-standards-for-hospital-pharmacy.pdf. Accessed 27 Aug 2015.
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None.
Rights and permissions
About this article
Cite this article
Bourne, R.S., Baqir, W. & Onatade, R. Pharmacist independent prescribing in secondary care: opportunities and challenges. Int J Clin Pharm 38, 1–6 (2016). https://doi.org/10.1007/s11096-015-0226-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-015-0226-9